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Abstract
Background. Diabetes mellitus is one of chronic metabolic disorder characterized by
hyperglycemia and abnormalities in carbohydrate, fat, and protein metabolism because of insulin
insufficiency. Diabetes mellitus is a chronic disorder which have consequencies in patients' quality of
life.
Objective. The research aimed to find out the description about quality of life in diabetic
patients and the influence of delivering drug information to the quality of life in diabetic patients who
got oral diabetic agents in Puskesmas Umbulharjo 1 Yogyakarta.
Methods. The research was a cohort study at Puskesmas Umbulharjo I. The inclusion criteria
were all diabetic patients who got oral diabetic agents and had been receiving the medication for at
least one month in Puskesmas Umbulharjo I, patients who are willing to be the respondents, dan the
living place of the patients can be reached by the researcher. The exclusion criteria was a patient who
had complicated disorder. There were 18 patients in the research who had inclusion criteria. The
data being analyzed was a primary data to identify quality of life that was measured using SF-36
questionnaire Indonesian version.
Outcome measured. Quality of life domain in diabetic patients
Results. The result of the research indicated that 8 domains were a (1) general health
perceptions (2) physical health problem (3) physical activities (4) emotional problems, (5) social
activities (6) bodily pain (7) vitality and (8) general mental health. The result from eight domains
showed that there was no corellation between the provision of drug information and quality of life in
diabetic patients (p > 0.05). In the other results showed that there was a significant corellation
between patient's adherence and quality of life in diabetic patients in three domains such as general
health perceptions, vitality, and general mental health (p < 0.05).
Conclusion. In conclusion, the provision of drug information did not affect the quality of life of
patients with diabetes mellitus (P>0.05), whereas the effect of compliance to quality of life resulted
that compliance of patients significantly influenced the quality of life of patients with diabetes
mellitus in 3 domains, namely physical activities, vitality, and general mental health (p <0.05).
Keywords : Diabetes mellitus, quality of life, delivering drug information , SF-36 questionnare
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INTRODUCTION
Diabetes mellitus is defined as a disease or
a chronic metabolic disorder with multiple
etiology characterised by high blood sugar levels
accompanied with disturbance of carbohydrate
metabolism, lipid and protein as a result of
insulin function insufficiency. Insufficiency of
insulin function may be caused by impaired or
deficient production of insulin by the beta cells
of Langerhans pancreas gland, or due to the lack
of responsiveness of body cells to insulin
(Anonim, 2005).
The development of the concept of
HRQOL (Health-related Quality of Life) or the
relationship of health and quality of life
improved in line with world health clinical
research in healthcare. HRQOL instruments are
divided into general and disease specific
instrument. Instruments Study Short Form 36
(SF-36) is one common instrument that has been
widely used to measure the HRQOL disease
chronic pain and other common illness (Magnus
et Al, 2007).
Research on quality of life is expected to
obtain an overview of the level of quality of life
of patients with diabetes mellitus who consumed
oral hypoglycemic drugs, so it will obtain the
suitable model for the provision of drug
information on patients with diabetes mellitus.
METHODS
Subjects
The study subjects were all the patients of
diabetes mellitus and get oral hypoglycemic
drugs in Puskesmas Umbulharjo I in April-May
2012 who meet the criteria for inclusion and
exclusion criteria. Inclusion criteria for the study
were all patients of diabetes mellitus that receive
oral hypoglycemic drugs and were undergoing
treatment at least 1 month in Puskesmas
Umbulharjo I, patients who were willing as a
respondent, and the respondent could be reached
by researchers. Exclusion criteria for the study
were patients who experienced complications of
other diseases.
Research Data Collection
Data collected in the form of primary data
obtained from research subjects by using an
instrument that has been tested, the Indonesian
version of the.SF-36. The patient's quality of life
data collection done at home while visiting a
patient's home, to see the remaining amount of
oral hypoglycemic drugs that have been drunk.
Before conducting interviews and
questionnaires, it should be ensured that the
selected respondent is in compliance with the
criteria of inclusion.
Analysis of results
In this stage, the processing and analysis
of the results of the study are to analyze the
influence of drug information and adherence to
the quality of life of patients with diabetes
mellitus who consumed oral hypoglycemic
drugs. Quality of life of patients assessed by the
SF-36 questionnaire, which contained 8-will do
assessment domains, namely the domain of
general health perceptions, physical health
problem, physical activities, emotional problem,
social activities, bodily pain, vitality, and general
mental health. From the domains, then do the
scoring with a scale of 0 to 100 with 100 being
the highest level.
RESULTS AND DISCUSSION
This study was conducted on 18 patients
who fit the inclusion and exclusion criteria.
Measurement of quality of life is intended to
compare and differentiate between two different
therapy with moral values and high morbidity
(Spilker, 1996). To measure the quality of life of
the patients, the study used the SF-36 instrument.
The SF-36 instrument is a general instrument
that can be used to measure the quality of life of
patients in various clinical disorders whether the
type is chronic illness or specific diseases.
Diabetes mellitus is a chronic disease
type, so it can analyze the patient's quality of life
using SF-36 instrument. The SF-36 has 8-scale
profile of functional health; the limitation of
physical activity due to existing health problems,
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social activity limitations due to physical and
emotional problems, whole body pain, general
mental health, restriction of daily activities due
to emotional problems, vitality of life, and
general health outlook (Wata, 2007). Seven
domains are analyzed by the Independent T-test
with a level of 95% while the emotional state of
domain analyzed by 2-related samples.
In Table I are data on the effect of drug
information to the quality of life. Provision of
drug information was limited to how to take the
medicine and the rules of use, due to time
constraints. The results showed that
administration of drug information does not
differ significantly (P> 0.05) on the quality of
life of patients in either eight domains, namely
general health, physical functioning, physical
condition, emotional state, physical function,
bodily pain, vitality, and mental state.So it can be
concluded that the provision of drug information
to patients does not affect the patient's quality of
life. This can occur because the information
presented is only how to take the medicine and
the rules of use, so there are some other things
that can affect the patient's quality of life such as
compliance of the patient.
Influence patient compliance to the
quality of life can be seen in Table II.
Compliance is defined as the extent to which a
person's behavior in terms of using medication
(is defined by how far a person's behaviour in
terms of drugs usage), following a diet, or
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Function
Domain
Average ± SD P Significance
With Drug Information
Without Drug Information
KU
56.93±17.19
58.79±16.33
0.817 Not Significant
With Drug Information
Without Drug Information
FF
67.22±33.64
82.22±15.43
0.242 Not Significant
With Drug Information
Without Drug Information
KF
38.88±39.74
30.55±42.89
0.675 Not Significant
With Drug Information
Without Drug Information
KE
363.495±125.896
363.495±125.896
0.181 Not Significant
With Drug Information
Without Drug Information
FS
72.22±27.79
76.38±14.58
0.696 Not Significant
With Drug Information
Without Drug Information
NT
58.61±22.77
63.05±18.65
0.657 Not Significant
With Drug Information
Without Drug Information
V
53.33±19.36
56.66±17.13
0.704 Not Significant
With Drug Information
Without Drug Information
KM
69.77±19.09
68.00±21.07
0.854 Not Significant
Table I. The Effect of Drug Information on Patient's Quality of Life
changing inlife style in accordance with medical
advice or health workers advice. As increasing
patient compliance does not arise, it is expected
that drug resistance can be detrimental (can
harm/can be harmful) to the patient itself, the
environment, recurrence and death (Melanie,
2009).
Oral hypoglycemic drug compliance seen
from the remaining number of oral
hypoglycemic drugs provided by the
pharmacists in Puskesmas Umbulharjo I that
were drunk by patients, whether in accordance
with the amount that should be taken or not, and
be seen as doing the interview at the patient’s
home.
From the results gained, showing that
compliance was not effected significantly (P >
0.05) in five domains, namely the domain of
general health, physical functioning, emotional
health, social functioning, and bodily pain. But
compliance significantly effects (P < 0.05), on
the 3 domains, namely the domain of physical
health, vitality, and mental health. It can be
concluded that compliance significantly
influence the quality of life of patients.
Overall, based on the test results of the
Independent T-test, it showed that the provision
of drug information and patient compliance give
no significant effects on the public health
domain. Itcan be seen in the table the value of
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FunctionDomain Average ±SD P Significance
Obedient
Disobedient
KU
59.58±18.11
55.71±14.61
0.632 Not Significant
Obedient
Disobedient
FF
85.00±10.27
61.87±35.14
0.064 Not Significant
Obedient
Disobedient
KF
52.50±44.79
12.50±18.89
0.032 Not Significant
Obedient
Disobedient
KE
362.995±126.224
362.995±126.224
0.181 Not Significant
Obedient
Disobedient
FS
78.75±15.64
68.75±27.54
0.345 Not Significant
Obedient
Disobedient
NT
61.50±17.00
60.00±25.10
0.082 Not Significant
Obedient
Disobedient
V
62.50±16.20
45.62±15.90
0.042 Significant
Obedient
Disobedient
KM
78.80±11.63
56.50±20.88
0.011 Significant
Table II. Compliance Influenceon Patient’sQuality Of Life
significant effect of drug information on the
quality of life of patients is 0.817 (> P 0.05) and
the value of the significant influence of
compliance to the quality of life of patients,
namely 0.632 (> P 0.05).
In the domain of physical function, it can
be assessed how the ability of a patient's daily
activities such as walking, bending, and lifting
heavy loads,whether the health conditions of
physical function may result in limitations of the
patient through physical activity. From the
research, the provision of drug information does
not affect the physical function domain. It can be
seen the value of significance is 0.242 (P > 0.05),
and compliance did not affect the physical
function domain, can be seen the significant
value is 0.064 (P > 0:05). It can be concluded that
the provision of drug information and patient
compliance has no effect on physical function
domain, whereas Wiyanti (2012) stated that the
physical function domain effect on age.
In the domain of physical conditions can
be assessed how much physical state interfere in
the work and activities of daily living. From the
research data that the provision of drug
information does not affect the physical state
visible domain of significant value in the table is
0.675 (P > 0.05), whereas the effect on patient
compliance domain visible physical state of
significant value in the table is 0.032 (P > 0.05),
so it can be concluded that the given drug
information or not given drug information does
not affect the quality of life of patients but
blindly obedient or not patients have a
significant effect on the quality of life of patients
is the physical state that disrupt their work and
daily activities.
In the emotional state domain, it used
statistical analysis with 2 related samples, it can
be seen some aspects of the patient-related mood
in doing the work and activities of daily living.
Provision of drug information and patient
compliance has no effect on the emotional state
of the domain, can be seen from the data table of
significance values are 0.181 and 0.181 (P>
0.05), so it can be concluded that with the drug
information was given or not, and how the
patient obedient or not, can not affect the
patient's emotional state. From patient
interviews, most of them stated that emotional
disorders such as anxiety do not interfere the
patient in performing daily activities or their
work.
In the domain of social function, it can be
evaluated that the patient's health or emotional
disturbance can disrupt activities or social
activities of the patient's family, friends,
neighbors, or groups. Provision of drug
information and patient compliance has no effect
on physical function domain can be seen in the
table of significance values 0.696 and 0.345.It
can be concluded that given or not given the drug
information and how the patientobedient or not,
has no effect on social functioning of patients.
And from the interviews, it is found that many
patients say health or emotional disorder that is
often felt they did not interfere with patient's
activity or social activities to family, friends,
neighbors, or groups.
In the bodily pain domain, it can evaluate
pain intensity and impact of pain on daily
activities both at work and activities inside and
outside the home. Provision of drug information
and patient compliance has no effect on bodily
pain domain views of significant value in the
table, namely 0.657 and 0.882. It can be
concluded that given or not given the drug
information and how the patientobedient or not
had no significant effect on the patient's pain.
In the domain of vitality, it evaluate the
level of fatigue, fatigue, and lethargy are often
perceived by the patient. Provision of drug
information does not affect the vitality domains,
but the effect on patient adherence vitality
domain can be seen from the significant value of
0.657 (P> 0.05), and 0.042 (P <0.05). How
obedient or not the patient will have an impact on
patient quality of life, especially its vitality
because one of the complaints experienced by
patients with diabetes mellitus is weak body,
then the non-adherent patients taking the
medication more frequently complain of weak
entities.
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In the mental health domain, it evaluate
general mental health including depression,
anxiety, and behavior control emotions by the
patient. Provision of drug information does not
affect the mental health domain, but the effect on
patient compliance mental health domain, it can
be seen from the significant value of 0.854 (P>
0.05), and 0.011 (P <0.05). How obedient or not
the patient will have an impact on the quality of
life of patients, especially in mental health
patients, as diabetes mellitus is a disease that is
difficult and long to be cured, it can make mental
health patients reduced the impact on patient
adherence. In the study of Wiyanti (2012),
quality of life of diabetes mellitus patients, there
are 2-type influential domains, one of them is
mental health, that is influenced by the duration
of the disease.
CONCLUSION
Based on the results of a study of 18
patients with diabetes mellitus and the use of oral
hypoglycemic drugs, showed that of the 8
domains tested, provision of drug information
does not affect the quality of life of patients with
diabetes mellitus (P> 0.05), whereas the effect of
adherence to quality measurement life result that
compliance of patients significantly influence
the quality of life of patients with diabetes
mellitus in 3 domains, namely physical health,
vitality, and mental health (p <0.05).
RECOMMENDATION
It is still needed to conduct research on
patients' compliance and quality of life with
diabetes mellitus for evaluating treatment with
time to improve the provision of information and
frequency of medications, as well as increasing
the number of research samples.
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